DZ2827A1 - New 19-nor 17-halogenated steroids, method and intermediates of preparation, application as medicaments and pharmaceutical compositions containing them. - Google Patents

New 19-nor 17-halogenated steroids, method and intermediates of preparation, application as medicaments and pharmaceutical compositions containing them.

Info

Publication number
DZ2827A1
DZ2827A1 DZ990127A DZ990127A DZ2827A1 DZ 2827 A1 DZ2827 A1 DZ 2827A1 DZ 990127 A DZ990127 A DZ 990127A DZ 990127 A DZ990127 A DZ 990127A DZ 2827 A1 DZ2827 A1 DZ 2827A1
Authority
DZ
Algeria
Prior art keywords
medicaments
intermediates
preparation
new
application
Prior art date
Application number
DZ990127A
Other languages
French (fr)
Inventor
Yamina Bouali
Jacques Mauger
Francois Nique
Van De Patrick Velde
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of DZ2827A1 publication Critical patent/DZ2827A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DZ990127A 1998-06-23 1999-06-22 New 19-nor 17-halogenated steroids, method and intermediates of preparation, application as medicaments and pharmaceutical compositions containing them. DZ2827A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9807898A FR2780060B1 (en) 1998-06-23 1998-06-23 NOVEL 17-NOR STEROIDS 17-HALOGENS, PROCESS AND INTERMEDIATES FOR PREPARATION, APPLICATION AS DRUGS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Publications (1)

Publication Number Publication Date
DZ2827A1 true DZ2827A1 (en) 2003-12-01

Family

ID=9527717

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990127A DZ2827A1 (en) 1998-06-23 1999-06-22 New 19-nor 17-halogenated steroids, method and intermediates of preparation, application as medicaments and pharmaceutical compositions containing them.

Country Status (37)

Country Link
US (2) US6423700B1 (en)
EP (1) EP1090027B1 (en)
JP (1) JP4509380B2 (en)
KR (1) KR20010034919A (en)
CN (1) CN1313862A (en)
AP (1) AP1579A (en)
AR (1) AR018916A1 (en)
AT (1) ATE237628T1 (en)
AU (1) AU771369B2 (en)
BR (1) BR9912206A (en)
CA (1) CA2336167A1 (en)
CZ (1) CZ296246B6 (en)
DE (1) DE69906972T2 (en)
DK (1) DK1090027T3 (en)
DZ (1) DZ2827A1 (en)
EA (1) EA003325B1 (en)
ES (1) ES2196879T3 (en)
FR (1) FR2780060B1 (en)
HK (1) HK1039945A1 (en)
HR (1) HRP20000893A2 (en)
HU (1) HUP0103194A3 (en)
ID (1) ID27410A (en)
IL (1) IL140416A (en)
MA (1) MA26656A1 (en)
MY (1) MY118101A (en)
NO (1) NO318381B1 (en)
NZ (1) NZ508535A (en)
PL (1) PL345073A1 (en)
PT (1) PT1090027E (en)
SK (1) SK19492000A3 (en)
TN (1) TNSN99130A1 (en)
TR (1) TR200003857T2 (en)
TW (1) TW550077B (en)
UA (1) UA66867C2 (en)
WO (1) WO1999067274A1 (en)
YU (1) YU80700A (en)
ZA (1) ZA200007355B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3922104B2 (en) * 2002-06-07 2007-05-30 富士通株式会社 Point management device, point management system, point management method, and point management program
FR2854403B1 (en) * 2003-04-29 2008-07-11 Aventis Pharma Sa NOVEL METHOD AND INTERMEDIATES FOR THE PREPARATION OF 17-HALOGENES 19-NOR-STEROID COMPOUNDS
FR2854402B1 (en) * 2003-04-29 2008-07-04 Aventis Pharma Sa NOVEL PROCESS AND INTERMEDIATES FOR PREPARING 19-NOR-STEROID COMPOUNDS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3079408A (en) * 1963-02-26 Ig-bisoxygenated iy-haloestra-
US3264327A (en) * 1962-07-27 1966-08-02 Syntex Corp 17alpha-fluoro-, 17beta-chlorofluoroacetoxy- and 17beta-methyl-delta4-and delta5-androstene derivatives
US3413321A (en) * 1966-06-03 1968-11-26 Du Pont Selected 17-fluoro-delta16 steroids
FR2528434B1 (en) * 1982-06-11 1985-07-19 Roussel Uclaf NOVEL 19-NOR STEROIDS SUBSTITUTED IN 11B AND POSSIBLY IN 2, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS A MEDICAMENT
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
FR2685332A1 (en) * 1991-12-20 1993-06-25 Roussel Uclaf NOVEL 19-NOR STEROUIDS HAVING IN THE POSITION 11BETA THIOCARBONIC CHAIN, PROCESS FOR PREPARING SAME, AND INTERMEDIATES THEREOF AND APPLICATION THEREOF AS MEDICAMENTS.
FR2757519B1 (en) 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc SUBSTITUTED STEROIDS IN POSITION 11, THEIR PREPARATION PROCESS, THEIR APPLICATION AS A MEDICAMENT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2761992B1 (en) * 1997-04-09 1999-06-11 Hoechst Marion Roussel Inc NOVEL 4-HALOGEN STEROIDS, THEIR PREPARATION PROCESS AND INTERMEDIATES, THEIR APPLICATION AS DRUGS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2771096B1 (en) * 1997-11-17 2000-08-11 Hoechst Marion Roussel Inc NOVEL 19-NOR STEROIDS, SUBSTITUTED IN 11BETA POSITION, PROCESS AND INTERMEDIATES FOR PREPARATION, APPLICATION AS DRUGS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
CZ296246B6 (en) 2006-02-15
TW550077B (en) 2003-09-01
HUP0103194A2 (en) 2002-01-28
IL140416A (en) 2005-07-25
CZ20004834A3 (en) 2001-06-13
TNSN99130A1 (en) 2005-11-10
US6423700B1 (en) 2002-07-23
FR2780060A1 (en) 1999-12-24
HK1039945A1 (en) 2002-05-17
PL345073A1 (en) 2001-12-03
DK1090027T3 (en) 2003-08-04
EP1090027A1 (en) 2001-04-11
EA200100069A1 (en) 2001-06-25
HRP20000893A2 (en) 2001-10-31
MY118101A (en) 2004-08-30
CN1313862A (en) 2001-09-19
BR9912206A (en) 2001-04-10
HUP0103194A3 (en) 2002-09-30
AU4270599A (en) 2000-01-10
SK19492000A3 (en) 2001-09-11
NZ508535A (en) 2002-08-28
AP1579A (en) 2006-02-22
TR200003857T2 (en) 2001-06-21
WO1999067274A1 (en) 1999-12-29
US6566542B2 (en) 2003-05-20
AU771369B2 (en) 2004-03-18
KR20010034919A (en) 2001-04-25
US20030022874A1 (en) 2003-01-30
MA26656A1 (en) 2004-12-20
YU80700A (en) 2003-10-31
UA66867C2 (en) 2004-06-15
ATE237628T1 (en) 2003-05-15
DE69906972D1 (en) 2003-05-22
EP1090027B1 (en) 2003-04-16
ZA200007355B (en) 2001-12-11
ID27410A (en) 2001-04-05
CA2336167A1 (en) 1999-12-29
AR018916A1 (en) 2001-12-12
NO20006573L (en) 2001-02-22
NO318381B1 (en) 2005-03-14
JP4509380B2 (en) 2010-07-21
FR2780060B1 (en) 2000-08-04
NO20006573D0 (en) 2000-12-21
AP2000002007A0 (en) 2000-12-31
ES2196879T3 (en) 2003-12-16
EA003325B1 (en) 2003-04-24
JP2002518516A (en) 2002-06-25
IL140416A0 (en) 2002-02-10
DE69906972T2 (en) 2004-02-05
PT1090027E (en) 2003-09-30

Similar Documents

Publication Publication Date Title
DZ2457A1 (en) New nicotinamide derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2634A1 (en) New pleuromutilin derivatives, process for their preparation and pharmaceutical compositions containing them.
FR2644789B1 (en) NOVEL 19-NOR, 3-CETO STEROIDS COMPRISING AN AMINOSUBSTITUTED 17-CHAIN, THEIR PREPARATION METHOD AND THE INTERMEDIATES THEREOF, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DZ2880A1 (en) Alkynyl-substituted quinoline-2-one derivatives, new process for their preparation and pharmaceutical compositions containing them.
DZ1889A1 (en) New quinoline derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2891A1 (en) New substituted tetrahydroquinoline derivatives, process for their preparation and pharmaceutical compositions containing them.
FR2707882B1 (en) New protein anti-mediator therapeutic kits, preparation process and pharmaceutical compositions containing them.
DZ2128A1 (en) New compounds, process for their preparation and pharmaceutical compositions containing them.
DZ2197A1 (en) 6-Phenylpyridyl-2-amine derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2963A1 (en) New substituted bicyclic derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ3038A1 (en) Novel modulators of glucocorticoid receptors, process for their preparation and pharmaceutical compositions containing them.
DZ1957A1 (en) New piperidine derivatives, process for their preparation and pharmaceutical compositions containing them.
DZ2944A1 (en) New azalides, process for their preparation and pharmaceutical compositions containing them.
DZ2188A1 (en) Quinoxalinedone derivatives, processes and intermediates for their preparation and pharmaceutical compositions containing them.
DZ2777A1 (en) New quinazolinamine derivatives process for their preparation and pharmaceutical compositions containing them.
DZ2751A1 (en) New calciolytic compounds process for their preparation and pharmaceutical compositions containing them.
FR2737721B1 (en) NOVEL BIPHENYL COMPOUNDS, THEIR PREPARATION METHOD AND INTERMEDIATES THEREOF, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DZ2498A1 (en) New quinoline derivatives process for their preparation and pharmaceutical compositions containing them.
FR2716195B1 (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and pharmaceutical compositions containing them
FR2715402B1 (en) New phenylimidazolines optionally substituted, their process and preparation intermediates, their use as medicaments and the pharmaceutical compositions containing them.
FR2705095B1 (en) New substituted indoles, process for their preparation and pharmaceutical compositions containing them.
MA26642A1 (en) NOVEL SULFONYLBENZENE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
EE03395B1 (en) Benzothiazolone derivatives, processes and intermediates used for their preparation, and pharmaceutical compositions containing them
FR2720397B1 (en) New oxathiolanes, process for their preparation and pharmaceutical compositions containing them.
FR2747680B1 (en) NOVEL STEROIDS, THEIR APPLICATION AS MEDICAMENTS, THEIR PREPARATION PROCESS, THE INTERMEDIATES THEREOF AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM